Melbourne scientists are teasing out how the "Hippo pathway" works at the molecular level, improving understanding of how it ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

Endocrine disruption during pregnancy and genetic drivers of bone disease were among the topics experts from UC San Francisco presented at the annual meeting of the Endocrine Society — ENDO 2025 — in ...

By understanding this newly revealed mechanism, scientists may now be able to design drugs that disable Hedgehog signaling at ...

A new preclinical study from Weill Cornell Medicine reveals that linoleic acid, a type of omega-6 fatty acid commonly found in seed oils and animal products, can promote the growth of triple-negative ...

Hormone therapy for metastatic prostate cancer can improve quality of life and longevity for those receiving treatment.

Last month, former President Joe Biden announced that he had been diagnosed with an aggressive form of prostate cancer. The news sparked a larger conversation about what exactly the best practices are ...

Adding Niraparib to standard therapy slows tumor growth and time to symptomatic progression in men with metastatic hormone sensitive prostate cancer.

PARP-ARPI Combo Sets New Standard for Metastatic Hormone-Sensitive Prostate Cancer — Radiographic progression cut, time to symptomatic worsening halved with niraparib and abiraterone ...

Early driver of prostate cancer aggressiveness Study links higher expression of the gene PROX1 to aggressive change in prostate tumor cells; FDA-approved class of drugs can disable PROX1 Date ...

Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant and clinically meaningful benefit for Pluvicto™ plus ...